ONS
ONS is a dietary supplement with 7 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
2
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
EAT-ING: Enhancing Anticancer Treatment Safety Via Immunomodulatory Nutritional Support in Advanced Gastrointestinal Cancers
Glycaemic Index Measurement of an Oral Nutritional Supplement With Biomarker Assessment and Lifestyle Monitoring in Healthy Participants
ONS in Gastric Cancer After Total Gastrectomy
Immunonutritional Supplement After Total Gastrectomy in Patients With Stage III Gastric Cancer
Dialysis Model for Outcome and Nutrition Decision
Clinical Trials (7)
EAT-ING: Enhancing Anticancer Treatment Safety Via Immunomodulatory Nutritional Support in Advanced Gastrointestinal Cancers
Glycaemic Index Measurement of an Oral Nutritional Supplement With Biomarker Assessment and Lifestyle Monitoring in Healthy Participants
ONS in Gastric Cancer After Total Gastrectomy
Immunonutritional Supplement After Total Gastrectomy in Patients With Stage III Gastric Cancer
Dialysis Model for Outcome and Nutrition Decision
Evaluating the Efficacy of a Novel Oral Supplement in Tackling Malnutrition in the Elderly
Glycemic Response to Oral Nutrition Supplements
All 7 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 7